1/26
Looks like no tags are added yet.
what causes an incompatible blood transfusion reaction
recipient has antibodies against antigens on the donor's erythrocytes
which antibody usually mediates ABO blood group transfusion reactions
IgM
what happens when IgM antibodies react with incompatible donor erythrocytes
agglutination, complement activation and intravascular haemolysis occur
what are the 4 clinical symptoms of acute incompatible blood transfusion reactions
fever
hypotension
nausea and vomiting
back and chest pain
what is the function of H gene in ABO antigen formation
it produces an enzyme that attaches fucose (Fuc) to the terminal galactose (Gal) of the precursor oligosaccharide, forming the H antigen
how is A blood group antigen formed
the A gene produces an enzyme that attaches N-acetylgalactosamine (NAGA) to the galactose residue of the H antigen
how is B blood group antigen formed
the B gene produces an enzyme that attaches an additional galactose residue to the H antigen
how is the AB blood group antigen formed
Individuals with both A and B genes produce both A and B antigens
what determines which ABO antibodies an individual naturally produces
Individuals generally produce antibodies against the ABO antigens they lack
what are the ABO blood groups, their genotypes, antigens and naturally occurring antibodies

why are group O individuals described as universal red blood cell donors
they lack A and B antigens on their erythrocytes, so their cells are not targeted by recipients' anti-A or anti-B antibodies
what is Rhesus (RhD) antigen
highly immunogenic membrane protein of approximately 30 kDa found on the surface of erythrocytes
what does it mean to be RhD-positive or RhD-negative
RhD-positive individuals possess the RhD antigen on their erythrocytes; RhD-negative individuals do not
what is haemolytic disease of newborn
condition in which maternal antibodies attack and destroy the red blood cells of an RhD-positive foetus or newborn
how does an RhD-negative mother become sensitised to RhD-positive foetal erythrocytes
during delivery, some foetal erythrocytes can cross the placenta into maternal circulation, exposing the mother to the RhD antigen and stimulating IgG production
why is a subsequent RhD-positive pregnancy at risk of haemolytic disease of the newborn
the previously sensitised mother has anti-RhD IgG antibodies that can cross the placenta and destroy the RhD-positive foetal erythrocytes
which antibody is responsible for haemolytic disease of the newborn
maternal IgG anti-RhD antibodies
what is Rhesus prophylaxis
administration of preformed anti-RhD antibodies to prevent an RhD-negative mother from becoming sensitised to RhD-positive foetal red blood cells
when is Rhesus prophylaxis given
Immediately after delivery of the first RhD-positive child
other clinical examples of type II hypersensitivity
what is immune thrombocytopenic purpura (ITP) in the context of Type II hypersensitivity
an antibody-mediated condition in which platelets are destroyed, reducing platelet numbers and impairing blood clotting
how can drugs trigger immune thrombocytopenic purpura
drug molecules bind to platelets, forming drug–platelet complexes that act as antigens and trigger an antibody response. Complement activation contributes to platelet destruction
what are purpuric lesions, and why can they develop in ITP
Purple or reddish skin lesions caused by bleeding beneath the skin due to reduced platelet numbers and impaired clotting
what is haemolytic anaemia in the context of Type II hypersensitivity
Antibody-mediated destruction of red blood cells, resulting in reduced erythrocyte numbers and anaemia
how can drugs cause haemolytic anaemia
drug-related antigens trigger antibodies that bind to red blood cells, leading to complement activation, opsonisation and erythrocyte destruction
what are the visible clinical feature of haemolytic anaemia
mild jaundice, caused by increased breakdown of red blood cells